Host-Directed Therapeutic for the treatment of Mycobacterium tuberculosis宿主导向疗法用于治疗分枝杆菌结核分枝杆菌(Mycobacterium tuberculosis)Microbiological ResearchIF6.92025-05-310PRE
Disturbances in the gut microbiota potentially associated with metabolic syndrome among patients living with HIV-1 and on antiretroviral therapy at Bafoussam Regional Hospital, CameroonDIABETOLOGY & METABOLIC SYNDROMEIF3.92025-03-150OAAI
The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of AstrocytesCELLSIF5.22022-10-172OAAI
APOBEC3, TRIM5α, and BST2 polymorphisms in healthy individuals of various populations with special references to its impact on HIV transmissionMICROBIAL PATHOGENESISIF3.52022-01-011PRE
KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicityMICROBIAL PATHOGENESISIF3.52021-12-013PRE
Impact of MBL-2 coding region polymorphism on modulation of HAND and HIV-1 acquisitionMICROBIAL PATHOGENESISIF3.52021-11-013PREAI
The Burden of Respiratory Viruses and Their Prevalence in Different Geographical Regions of India: 1970-2020FRONTIERS IN MICROBIOLOGYIF4.52021-08-3124OAAI
HIV-Associated Neurotoxicity: The Interplay of Host and Viral ProteinsMEDIATORS OF INFLAMMATIONIF4.22021-08-2529OAAI
GeneXpert HIV-1 quant assay, a new tool for scale up of viral load monitoring in the success of ART programme in IndiaBMC INFECTIOUS DISEASESIF32017-07-2118OAAI